Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade
- PMID: 1330172
- PMCID: PMC1907851
- DOI: 10.1111/j.1476-5381.1992.tb12742.x
Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade
Abstract
1. The effects of epinine or dopamine (both 1-10 micrograms kg-1 min-1) on systemic haemodynamics and plasma concentrations of catecholamines and prolactin were studied in conscious pigs before and after combined non-selective alpha- and beta-adrenoceptor blockade. 2. The plasma concentrations of the two compounds did not differ from each other over the entire dose-range. 3. Epinine increased aortic blood flow (AoBF, 24 +/- 6%), which was due to an increase in heart rate (HR) for doses less than 10 micrograms kg-1 min-1. At 10 micrograms kg-1 min-1, HR decreased slightly (10 +/- 3%, as compared to the value obtained at 5 micrograms kg-1 min-1) and stroke volume increased up to 15% (P < 0.05). Mean arterial pressure (MAP, 99 +/- 3 mmHg at baseline) decreased dose-dependently (14 +/- 2%, P < 0.05) up to the infusion rate of 5 micrograms kg-1 min-1, but increased by 4.0 +/- 1.8 mmHg during infusion of 10 micrograms kg-1 min-1. Systemic vascular resistance (SVR) decreased up to 23 +/- 3% for doses less than 10 micrograms kg-1 min-1, but did not change further during infusion of the highest dose. LVdP/dtmax increased during the two highest infusion rates up to 22 +/- 6% (P < 0.05). After the infusion was stopped there was an abrupt increase in HR (18 +/- 4%, P < 0.05) and a further decrease in SVR before all parameters returned to baseline.4. Dopamine caused increases in AoBF (27 +/- 3%) similar to epinine, the only difference being that HR continued to increase (32 +/- 5%) and MAP (13 +/- 3%) and SVR continued to decrease (31 +/- 3%) over the entire dose-range. The increase in LVdP/dt,,,, at the highest dose (48 +/- 4%, P <0.05) was more pronounced than with epinine.5. Adrenoceptor blockade inhibited all epinine-induced changes, but did not affect the dopamineinduced changes in AoBF, SVR and MAP, but attenuated the increases in HR and LVdP/dtmax.6. Noradrenaline (NA) and adrenaline (Ad) concentrations did not change during infusion of epinine or dopamine, but NA increased by 50% within 2.5 min after stopping the infusion of epinine. After adrenoceptor blockade NA and Ad concentrations did not change during infusion of dopamine, which contrasted with a decrease of 55 +/- 5% (P<0.05) in NA during infusion of epinine.7. Prolactin concentrations decreased gradually from 480 +/- 40 pg ml-' to 270 +/- 50 pg ml1' (P<0.05) during infusion of epinine, but did not change significantly during dopamine infusion.8. The differential effects of epinine and dopamine on MAP, SVR, plasma NA (before and after adrenoceptor blockade) and prolactin, leads us to conclude that in conscious pigs, epinine is a more potent a, P2 and D2-receptor agonist, but a weaker D,-receptor agonist than dopamine.
Similar articles
-
Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):429-37. doi: 10.1007/BF00172781. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8532072
-
Effect of epinine on systemic hemodynamics and regional blood flow in conscious pigs.J Cardiovasc Pharmacol. 1992 Apr;19(4):580-6. doi: 10.1097/00005344-199204000-00015. J Cardiovasc Pharmacol. 1992. PMID: 1380601
-
Evidence against a role for dopamine D1 receptors in the myocardium of the pig.Br J Pharmacol. 1991 Sep;104(1):246-50. doi: 10.1111/j.1476-5381.1991.tb12414.x. Br J Pharmacol. 1991. PMID: 1686206 Free PMC article.
-
Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.Dan Med Bull. 1998 Jun;45(3):282-97. Dan Med Bull. 1998. PMID: 9675540 Review.
-
[Ibopamine--pharmacologic principles].Z Kardiol. 1991;80 Suppl 8:63-6. Z Kardiol. 1991. PMID: 1686693 Review. German.
Cited by
-
Pharmacotherapy of congestive heart failure. Currently used and experimental drugs.Pharm World Sci. 1994 Dec 2;16(6):234-42. doi: 10.1007/BF02178563. Pharm World Sci. 1994. PMID: 7889021 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous